Imaging Biometrics calls first-half profit a 'decisive first step'

Imaging Biometrics calls first-half profit a 'decisive first step' Proactive uses images sourced from ShutterstockImaging Biometrics Ltd (LSE:IBAI, FRA:5Y1) returned to profit in the first half of 2026 after generating higher revenue and making a sharp reduction in administrative costs. An operating profit of £88,678 was produced, compared with an £89,652 loss a year earlier. Chief executive Trevor Brown called the return to profit a "decisive first step", but said the priority was to convert clinical progress into faster recurring revenue. The company's IB Clinic imaging platform gained further clinical validation from a Phase II study involving 146 patients across 33 sites. Imaging Biometrics is seeking a partner to advance its gallium maltolate programme for rare paediatric brain cancers.